TrialEuropean journal of neurology2024

Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid-refractory multiple sclerosis relapses.

Ioannis Vardakas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.